Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Lucid Diagnostics shares are trading higher after the company announced data from its ESOGUARD BE-1 prospective, international, multicenter, single-arm study conducted to clinically validate performance of the EsoGuard Esophageal DNA test on samples collected with the EsoCheck Esophageal Cell Collection Device for detection of esophageal precancer and esophageal adenocarcinoma in a screening population.

Author: Benzinga Newsdesk | July 02, 2024 08:06am

Posted In: LUCD

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/16/2024 Vestis Corporation (VSTS)

07/22/2024 Biogen Inc. (BIIB)